4.7 Article

A disease-associated Aifm1 variant induces severe myopathy in knockin mice

期刊

MOLECULAR METABOLISM
卷 13, 期 -, 页码 10-23

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.molmet.2018.05.002

关键词

Akt/mTOR signaling; Apoptosis-inducing factor (AIF); 1C metabolism; Mitochondria; Mitochondrial diseases; Oxidative phosphorylation

资金

  1. DZNE institutional budget
  2. Helmholtz cross-program topic Metabolic Dysfunction and Aging and Metabolic Programming (AMPro)
  3. Germany through the Bundesministerium fur Bildung und Forschung (BMBF) under the aegis of the EU Joint Programme-Neurodegenerative Disease Research (Cellular Bioenergetics of Neurodegenerative Diseases, CeBioND)
  4. Marie Sklodowska-Curie grant [676144]
  5. Marie Curie Actions (MSCA) [676144] Funding Source: Marie Curie Actions (MSCA)

向作者/读者索取更多资源

Objective: Mutations in the AIFM1 gene have been identified in recessive X-linked mitochondrial diseases. Functional and molecular consequences of these pathogenic AIFM1 mutations have been poorly studied in vivo. Methods/results: Here we provide evidence that the disease-associated apoptosis-inducing factor (AIF) deletion arginine 201 (R200 in rodents) causes pathology in knockin mice. Within a few months, posttranslational loss of the mutant AIF protein induces severe myopathy associated with a lower number of cytochrome c oxidase-positive muscle fibers. At a later stage, Aifm1 (R200 del) knockin mice manifest peripheral neuropathy, but they do not show neurodegenerative processes in the cerebellum, as observed in age-matched hypomorphic Harlequin (Hq) mutant mice. Quantitative proteomic and biochemical data highlight signaling. Conclusion: Our findings indicate metabolic defects and distinct tissue-specific vulnerability due to a disease-causing AIFM1 mutation, with many pathological hallmarks that resemble those seen in patients. (C) 2018 The Authors. Published by Elsevier GmbH.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据